The efficacy and safety of direct-acting antiviral drugs in the management of hepatitis C virus-related arthritis

[1] Thomas DL(2013)Global control of hepatitis C: where challenge meets opportunity Nat Med 19 850-1560

[2] Jimenez AP(2010)HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt Gut 59 1554-115

[3] Eldin NS(2000)Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence Hepatology. 32 111-53

[4] Rimlinger F(2016)The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment Liver international: official journal of the International Association for the Study of the Liver 37 45-80

[5] El-Daly M(2011)A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt Liver Int 31 61-746

[6] El-Hariri H(2017)Extrahepatic manifestations of HCV: the role of direct acting antivirals Expert Rev Anti-Infect Ther 15 737-244

[7] El-Hoseiny M(2007)Extrahepatic manifestations of chronic HCV infection Journal of Gastrointestinal and Liver Diseases 16 65-48

[8] Abdel-Aziz F(2007)A closer look at pain and hepatitis C: preliminary data from a veteran population J Rehabil Res Dev 44 231-1782

[9] Habib M(2004)Joint sonography in asymptomatic patients with HCV correlated hepatitis Clin Exp Rheumatol 22 43-518

[10] Mohamed MK(2016)Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study Ann Rheum Dis 75 1777-913

[1] Thomas DL(2013)Global control of hepatitis C: where challenge meets opportunity Nat Med 19 850-1560

[2] Jimenez AP(2010)HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt Gut 59 1554-115

[3] Eldin NS(2000)Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence Hepatology. 32 111-53

[4] Rimlinger F(2016)The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment Liver international: official journal of the International Association for the Study of the Liver 37 45-80

[5] El-Daly M(2011)A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt Liver Int 31 61-746

[6] El-Hariri H(2017)Extrahepatic manifestations of HCV: the role of direct acting antivirals Expert Rev Anti-Infect Ther 15 737-244

[7] El-Hoseiny M(2007)Extrahepatic manifestations of chronic HCV infection Journal of Gastrointestinal and Liver Diseases 16 65-48

[8] Abdel-Aziz F(2007)A closer look at pain and hepatitis C: preliminary data from a veteran population J Rehabil Res Dev 44 231-1782

[9] Habib M(2004)Joint sonography in asymptomatic patients with HCV correlated hepatitis Clin Exp Rheumatol 22 43-518

[10] Mohamed MK(2016)Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study Ann Rheum Dis 75 1777-913